Anticoagulant activities of curcumin and its derivative

BMB Reports

Volumn 45, Issue 4, 2012, Pages 221-226

  Kim, Dong Chan ^a   Ku, Sae Kwang ^b   Bae, Jong Sup ^c  

^a NEUORNEX Inc   (South Korea)

^b Daegu Haany University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

aPTT; Curcumin; HUVECs; PT

Indexed keywords

ANTICOAGULANT AGENT; BIS(4-HYDROXYCINNAMOYL)METHANE; BLOOD CLOTTING FACTOR 10A; CURCUMIN; DIDEMETHOXYCURCUMIN; DRUG DERIVATIVE; THROMBIN;

ANIMAL; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HUMAN; MALE; METABOLISM; MOUSE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTICOAGULANTS; BLEEDING TIME; BLOOD COAGULATION; CELLS, CULTURED; CURCUMIN; FACTOR XA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBIN;

CURCUMA LONGA;

EID: 84861807247     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.4.221     Document Type: Article

References (41)

1. Davie, E. W. (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74, 1-6.
2. Davie, E. W., Fujikawa, K. and Kisiel, W. (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370.
3. Hoffman, M. M. and Monroe, D. M. (2005) Rethinking the coagulation cascade. Curr. Hematol. Rep. 4, 391-396.
4. Hoffmann, J. N., Vollmar, B., Romisch, J., Inthorn, D., Schildberg, F. W. and Menger, M. D. (2002) Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit. Care. Med. 30, 218-225.
5. Monroe, D. M., Hoffman, M. and Roberts, H. R. (2002) Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381-1389.
6. Quinn, C., Hill, J. and Hassouna, H. (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 13, 229-238.
7. Della Valle, P., Crippa, L., Garlando, A. M., Pattarini, E., Safa, O., Vigano D'Angelo, S. and D'Angelo, A. (1999) Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica 84, 1065-1074.
8. Furie, B. and Furie, B. C. (2005) Thrombus formation in vivo. J. Clin. Invest. 115, 3355-3362.
9. Jurenka, J. S. (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev. 14, 141-153.
10. Bengmark, S., Mesa, M. D. and Gil, A. (2009) Plant-derived health: the effects of turmeric and curcuminoids. Nutr. Hosp. 24, 273-281.
11. Joshi, J., Ghaisas, S., Vaidya, A., Vaidya, R., Kamat, D. V., Bhagwat, A. N. and Bhide, S. (2003) Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J. Assoc. Physicians. India. 51, 1055-1060.
12. Ammon, H. P. and Wahl, M. A. (1991) Pharmacology of Curcuma longa. Planta. Med. 57, 1-7.
13. Bao, W., Li, K., Rong, S., Yao, P., Hao, L., Ying, C., Zhang, X., Nussler, A. and Liu, L.;1; (2010) Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction. J. Ethnopharmacol. 128, 549-553.
14. Shankar, R., de la Motte, C. A., Poptic, E. J. and DiCorleto, P. E. (1994) Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269, 13936-13941.
15. Bachmeier, B., Nerlich, A. G., Iancu, C. M., Cilli, M., Schleicher, E., Vene, R., Dell'Eva, R., Jochum, M., Albini, A. and Pfeffer, U. (2007) The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell. Physiol. Biochem. 19, 137-152.
16. Aggarwal, B. B., Sundaram, C., Malani, N. and Ichikawa, H. (2007) Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75.
17. Inoue, K., Nomura, C., Ito, S., Nagatsu, A., Hino, T. and Oka, H. (2008) Purification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin by high-speed countercurrent chromatography. J. Agric. Food Chem. 56, 9328-9336.
18. Greenwald, P., Milner, J. A., Anderson, D. E. and McDonald, S. S. (2002) Micronutrients in cancer chemoprevention. Cancer Metastasis Rev. 21, 217-230.
19. Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A. and Cole, G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370-8377.
20. Zeitlin, P. (2004) Can curcumin cure cystic fibrosis? N. Engl. J. Med. 351, 606-608.
21. Ahsan, H., Parveen, N., Khan, N. U. and Hadi, S. M. (1999) Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem. Biol. Interact. 121, 161-175.
22. Sreejayan, N. and Rao, M. N. (1996) Free radical scavenging activity of curcuminoids. Arzneimittelforschung 46, 169-171.
23. Thapliyal, R., Deshpande, S. S. and Maru, G. B. (2001) Effects of turmeric on the activities of benzo(a)pyrene-induced cytochrome P-450 isozymes. J. Environ. Pathol. Toxicol. Oncol. 20, 59-63.
24. Syu, W. J., Shen, C. C., Don, M. J., Ou, J. C., Lee, G. H. and Sun, C. M. (1998) Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. J. Nat. Prod. 61, 1531-1534.
25. Guo, L. Y., Cai, X. F., Lee, J. J., Kang, S. S., Shin, E. M., Zhou, H. Y., Jung, J. W. and Kim, Y. S. (2008) Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo. Arch. Pharm. Res. 31, 490-496.
26. Li, Y. B., Gao, J. L., Lee, S. M., Zhang, Q. W., Hoi, P. M. and Wang, Y. T. (2011) Bisdemethoxycurcumin protects endothelial cells against t-BHP-induced cell damage by regulating the phosphorylation level of ERK1/2 and Akt. Int. J. Mol. Med. 27, 205-211.
27. Liu, Y. L., Yang, H. P., Gong, L., Tang, C. L. and Wang, H. J. (2011) Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines. Mol. Med. Rep. 4, 675-679.
28. Sugo, T., Nakamikawa, C., Tanabe, S. and Matsuda, M. (1995) Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J. Biochem. 117, 244-250.
29. Rao, L. V., Rapaport, S. I. and Lorenzi, M. (1988) Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 71, 791-796.
30. Ghosh, S., Ezban, M., Persson, E., Pendurthi, U., Hedner, U. and Rao, L. V. (2007) Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J. Thromb. Haemost. 5, 336-346.
31. Kaiser, L. and Sparks, H. V. Jr. (1987) Endothelial cells. Not just a cellophane wrapper. Arch. Intern. Med. 147, 569-573.
32. Chong, A. Y., Blann, A. D. and Lip, G. Y. (2003) Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM 96, 253-267.
33. Surapisitchat, J., Hoefen, R. J., Pi, X., Yoshizumi, M., Yan, C. and Berk, B. C. (2001) Fluid shear stress inhibits TNF- alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. U.S.A. 98, 6476-6481.
34. Berk, B. C., Abe, J. I., Min, W., Surapisitchat, J. and Yan, C. (2001) Endothelial atheroprotective and anti-inflammatory mechanisms. Ann. N. Y. Acad. Sci. 947, 93-109; discussion 109-111.
35. Yoshizumi, M., Fujita, Y., Izawa, Y., Suzaki, Y., Kyaw, M., Ali, N., Tsuchiya, K., Kagami, S., Yano, S., Sone, S. and Tamaki, T. (2004) Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Exp. Cell. Res. 292, 1-10.
36. Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, I. K., Rajasekharan, K. N. and Aggarwal, B. B. (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 76, 1590-1611.
37. Somparn, P., Phisalaphong, C., Nakornchai, S., Unchern, S. and Morales, N. P. (2007) Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharm. Bull. 30, 74-78.
38. Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S., Murakami, A., Sethi, G., Limtrakul, P., Badmaev, V. and Aggarwal, B. B. (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28, 1765-1773.
39. Fischer, K. G. (2007) Essentials of anticoagulation in hemodialysis. Hemodial. Int. 11, 178-189.
40. Bae, J. S. and Rezaie, A. R. (2008) Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 100, 101-109.
41. Dejana, E., Callioni, A., Quintana, A. and de Gaetano, G. (1979) Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb. Res. 15, 191-197.